z-logo
open-access-imgOpen Access
Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension
Author(s) -
James P. Sheppard,
Sarah Stevens,
Richard Stevens,
Una Martin,
Jonathan Mant,
Richard Hobbs,
Richard J. McManus
Publication year - 2018
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2018.4684
Subject(s) - medicine , intensive care medicine
Evidence to support initiation of pharmacologic treatment in low-risk patients with mild hypertension is inconclusive, with previous trials underpowered to demonstrate benefit. Clinical guidelines across the world are contradictory.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom